Integra Lifesciences Holdings (IART) Market Capitalization (2009 - 2026)

Integra Lifesciences Holdings has disclosed Market Capitalization across 18 years of filings, most recently posting $1.4 billion for Q2 2026.

• In Q2 2026, Market Capitalization rose 46.11% year-over-year to $1.4 billion; the TTM figure through Jun 2026 stood at $1.4 billion (up 46.11% YoY), while the FY2025 annual figure was $968.0 million, down 44.73% from the prior year.
• Market Capitalization came in at $1.4 billion for Q2 2026 at Integra Lifesciences Holdings, up from $732.8 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $5.3 billion in Q1 2022 to a low of $732.8 million in Q1 2026.
• Average Market Capitalization over 5 years is $2.6 billion, with a median of $2.5 billion recorded in 2024.
• Year-over-year, Market Capitalization plunged 57.71% in 2025 and jumped 46.11% in 2026.
• Over 5 years, Market Capitalization stood at $4.6 billion in 2022, then dropped by 25.58% to $3.4 billion in 2023, then tumbled by 48.59% to $1.8 billion in 2024, then plunged by 44.73% to $968.0 million in 2025, then soared by 44.3% to $1.4 billion in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $1.4 billion in Q2 2026, $732.8 million in Q1 2026, and $968.0 million in Q4 2025.